Physician profile
Jesus Jimenez
NPI 1003975509
$13,050.96
in general payments reported to CMS, 2019-2025
22 companies · $19.96 in 2025
The $19.96 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $659 · 2021: $346 · 2022: $1,312 · 2023: $10K · 2024: $38.21 · 2025: $19.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,750 · Food and Beverage: $1,427 · Travel and Lodging: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,750.00 |
| Food and Beverage | $1,427.04 |
| Travel and Lodging | $975.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,307.04 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,225.41 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Cvrx, INC. | $743.07 | 2019-2023 | Barostim Neo System |
| Boston Scientific Corporation | $384.62 | 2019-2023 | |
| Penumbra, INC. | $379.94 | 2021-2023 | Indigo System |
| Bolton Medical INC | $320.25 | 2022 | |
| Janssen Pharmaceuticals, INC | $149.15 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $98.51 | 2022 | |
| Dilon Technologies, INC. | $78.29 | 2023-2025 | Hemoblast Bellows |
| Davol INC. | $69.79 | 2023 | Phasix Mesh |
| Tela Bio, INC. | $44.31 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $39.13 | 2021 | |
| Ethicon US, LLC | $37.09 | 2019-2021 | |
| Covidien LP | $32.51 | 2020 | |
| Medshape, INC. | $26.32 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.40 | 2023 | Diamondback Coronary |
| Medtronic, INC. | $18.81 | 2022 | |
| Smith+Nephew, INC. | $18.44 | 2023 | Collagenase Santyl |
| Cook Medical LLC | $18.03 | 2023 | Zilver Ptx |
| Lemaitre Vascular, INC. | $13.27 | 2022 | |
| Acera Surgical, INC. | $13.15 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.